Antithrombotic Therapy in Patients Undergoing Coronary Angioplasty
Authors:
- Jeffrey J. PopmaJPJeffrey J. Popma
- Jeffrey WeitzJWJeffrey Weitz
- John A. BittlJBJohn A. Bittl
- E. Magnus OhmanEOE. Magnus Ohman
- Richard E. KuntzRKRichard E. Kuntz
- Alexandra J. LanskyALAlexandra J. Lansky
- Spencer B. KingSKSpencer B. King
Abstract
No abstract availableThis publication has 112 references indexed in Scilit:
- Subcutaneous heparin in postangioplasty management: Comparative trial with intravenous heparinAmerican Heart Journal, 1993
- Preprocedural anticoagulation does not reduce angioplasty heparin requirementsAmerican Heart Journal, 1993
- Fish oil supplements for prevention of restenosis after coronary angioplastyInternational Journal of Cardiology, 1992
- Multi-Hospital Eastern Atlantic Restenosis Trial II: A placebo-controlled trial of thromboxane blockade in the prevention of restenosis following coronary angioplastyAmerican Heart Journal, 1991
- The role of antiplatelet agents in modifying the extent of restenosis following percutaneous transluminal coronary angioplastyAmerican Heart Journal, 1990
- A Randomized Trial Comparing Ticlopidine Hydrochloride with Aspirin for the Prevention of Stroke in High-Risk PatientsNew England Journal of Medicine, 1989
- Effect of 18- to 24-hour heparin administration for prevention of restenosis after uncomplicated coronary angioplastyAmerican Heart Journal, 1989
- Reduction in the Rate of Early Restenosis after Coronary Angioplasty by a Diet Supplemented with n–3 Fatty AcidsNew England Journal of Medicine, 1988
- Coronary artery spasm after administration of dextran 40: Implications concerning percutaneous transluminal coronary angioplastyAmerican Heart Journal, 1986
- Coumadin and aspirin in prevention of recurrence after transluminal coronary angioplasty: a randomized study.Circulation, 1984